News & Blog

MaxWell Monthly Must-Reads (March 2018)

Today, we are launching a new blog series called MaxWell Monthly Must-Reads. Every month, we will feature interesting articles related to neuroscience, stem cell technology, drug discovery, and safety pharmacology. In this edition, we focus on Methods. We value well-designed experimental methods and protocols because they are key to new discoveries and ground-breaking results. Here, we include recent techniques for the generation of functionally active iPSC-derived neurons and brain organoids. We also feature a new single cell manipulation technique called…

Read More

10 Years Venture Kick Ceremony | MaxWell Biosystems is a Global Shaper

MaxWell Biosystems joined the celebration of Venture Kick’s 10-year anniversary last 29 November 2017. Held in Schlieren, the ceremony welcomed 500 guests–all involved in the Swiss innovation, entrepreneurship, and investment community. Venture Kick included a variety of events during the evening, such as a startup exhibition, speeches, guitar concert, and a fashion show. Everyone enjoyed the sumptuous dinner, desserts, and drinks. Global Shapers Venture Kick nominated high-impact startups for each of the ten years since the program started. The Global…

Read More

MaxWell Biosystems at European Retina Meeting 2017

From October 5th to the 7th, MaxWell Biosystems hosted a booth at the European Retina Meeting, in Paris, France. The conference attracted retina experts, researchers, and students. Paris was a great host, and MaxWell Biosystems even had the opportunity to attend a gala dinner in the city. MaxWell Biosystems would like to thank the organizers for a job well done!   Conference attendees loved the levitating MaxOne chip on display. Additionally, ERM 2017 gave MaxWell Biosystems the opportunity to debut the brand new Tissue Holder, specifically made for retinal applications.   We’re excited to…

Read More

MaxWell Biosystems at iForum 2017 in London

On September 28, 2017, MaxWell Biosystems’ VP of Scientific Affairs, Michele Fiscella, travelled to London to meet with stem cell researchers from academia, and the pharma and biotech industries. Michele presented results from using the MaxOne platform with induced pluripotent stem cells (iPSCs) in a presentation titled, “High-resolution microelectrode array platform for biomarker discovery and novel functional assays with human iPSC-derived neurons.”   After presenting promising results and receiving a positive reception from researchers at iForum, Michele is excited about the potential for using MaxWell Biosystems’…

Read More

MaxWell Biosystems technology in “The Secrets of Vision”

MaxWell Biosystems was excited to see Dr. Michele Fiscella, VP Scientific Affairs, featured in “The Secrets of Vision”. Michele discussed the state of vision disease research. The video is part of a film series produced by Systems X, the Swiss Initiative in Systems Biology. “The Secrets of Vision” tracks the increasing importance of research on vision-related diseases — with the end goal of developing effective drugs and treatment. In the feature, Michele explains how high-density microelectrode array systems, such as MaxOne, can accelerate this type of retinal cell research. He comments, “High…

Read More
Twitter Updates

Mattenstrasse 26
4058 Basel, Switzerland

+41 61 551 10 70

+41 61 551 10 71